Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

JPMorgan : Top five questions investors are asking - BofA

Published 2024-03-08, 12:58 p/m
Updated 2024-03-08, 12:58 p/m
© REUTERS

Bank of America analysts reiterated a Buy rating on JPMorgan (NYSE:JPM) in a note this week, assessing the top five questions investors are asking about the company.

Analysts maintained a $210 price target on the banking stock, stating that the single biggest risk factor is the company's CEO succession.

"Street overly focused on the day one stock impact, but we believe the real question that investors should be asking is whether the next CEO will be able to retain (and cultivate) the quality of talent, that has been a hallmark of Mr. Dimon's tenure," analysts pointed to Berkshire Hathaway as a potential template for a smooth transition.

Furthermore, regulatory outlook and capital deployment are a significant focus, according to BofA, with JPM operating with ~300bp of excess CET1 capital.

When it comes to tech spending, Bank of America acknowledges JPM has been a leader in tech research and development. However, they feel the question is "whether these investments can expand JPM's lead relative to peers, drive superior growth/market share gains, boost franchise efficiency."

Next, while BofA feels investors are watching for potential tail risk events from higher for longer rates for the entire industry, they state there has also been a focus on potential areas of vulnerability for JPM that "could spring a negative surprise, either on credit quality, or due to disruption from non-banks (Big Tech, digital start-ups, private credit)."

Finally, BofA notes that JPM has delivered an average ROTCE of ~20% over the last three years compared to 17% management through cycle target.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"While higher rates have clearly served as a tailwind, there is a valid question among investors on whether structurally higher interest rates, combined with capital optimization could lead to a better than targeted return profile," the firm concluded.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.